Steris Plc (STE31) Return on Assets ROA from the first quarter of 2026 to first quarter of 2022 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Steris Plc  (NYSE: STE31)


Steris Plc's ROA from the first quarter of 2026 to the first quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Steris Plc's ROA in the first quarter of 2026?
Steris Plc achieved a return on average assets (ROA) of 1.07 % in its first quarter of 2026, which is below Steris Plc's average return on assets, which stands at 4.52%.

ROA has improved compared to -0.27% in the third quarter of 2023, due to net income growth.

However, within the Healthcare sector 249 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2023 from 3094 to 3442.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
I. Quarter		 (Dec 31 2022)
III. Quarter		 (Sep 30 2022)
II. Quarter		 (Jun 30 2022)
I. Quarter		 (Mar 31 2022)
IV. Quarter
Y / Y Total Assets Change 15.16 % 74.89 % -11.28 % -8.11 % 66.98 %
Y / Y Net Income Change 286.14 % -13.82 % - - -40.95 %
Net Income (TTM) in million 120 -29 -9 376 243
Return On Assets (TTM) 1.07 % -0.27 % -0.1 % 3.78 % 2.38 %
STE31's Total Ranking # 3442 # 3094 # 1872 # 2157 # 2178
Total Assets (TTM) in million 12,383 11,237 10,296 10,990 10,753
Seq. Total Assets Change 10.2 % 9.14 % -6.32 % 2.21 % 67.35 %
Seq. Net Income Change 62.98 % - - 112.77 % -63.62 %

STE31's 5 Years Annual ROA >> Back to STE31 Management Effectiveness >> Compare STE31 ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 80
Sector # 250
Overall # 3349

Return On Assets Statistics
High Average Low
7.99 %
4.52 %
-0.26 %
(Dec 31 2020)  





Financial Statements
Steris Plc's Assets $ 12,383 million STE31's Balance sheet
Steris Plc's Income $ 201 million Quarterly STE31's Income Statement
STE31's Income by Division See STE31's Income by Division



Annual Return On Assets (Mar 31 2022)
FY 2022		 (Mar 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2017)
FY 2019
FY
Y / Y Total Assets Change 74.89 % 21.33 % -1.65 % - -
Total Assets in million 11,237 6,426 5,296 5,385 0
Y / Y Net Income Change -38.8 % -2.68 % 268.62 % - -
Net Income in million 243 397 408 111 0
Annual Return On Assets 2.16 % 6.18 % 7.7 % 2.05 % -

STE31's 5 Years Annual ROA >> Back to STE31 Management Effectiveness >> Compare STE31 ROA to its Competitors



Comment on STE31's ROA in the fiscal year ending 2022
In the fiscal year 2022 Steris Plc's ROA decreased compared to previous year to 2.16 %, due to deterioration of net income -38.8 % to $242.87 million, from $396.87 million a year ago, as STE31's assets were $11,237.45 million.


More Return On Assets Ratios
STE31's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
STE31's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for STE31's Competitors
Subscribers only: Roa for Steris Plc's Suppliers
Subscribers only: Return On Assets for STE31's Customers

You may also want to know
STE31's Roi STE31's Inventory Turnover Ratio STE31's Growth Rates STE31's Dividend Comparisons
STE31's Profitability Ratios STE31's Asset Turnover Ratio STE31's Dividend Growth
STE31's Roe STE31's Valuation Ratios STE31's Financial Strength Ratios STE31's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA
Vaso Corporation  2.92 %
Collegium Pharmaceutical Inc   2.72 %
National Vision Holdings Inc   2.53 %
Conmed Corporation  2.44 %
Merck and Co Inc   2.42 %
Privia Health Group Inc   2.41 %
Lifestance Health Group Inc   2.33 %
Bio rad Laboratories Inc   2.21 %
Pfizer Inc  2.12 %
Mimedx Group Inc   1.99 %
Revvity Inc  1.97 %
Alkermes Plc   1.96 %
Becton Dickinson And Company  1.77 %
Teva Pharmaceutical Industries Limited  1.77 %
Immucell Corporation  1.76 %
Envista Holdings Corporation  1.69 %
Atricure Inc   1.62 %
Black Hawk Acquisition Corporation  1.56 %
Repligen Corp  1.41 %
Omada Health Inc   1.41 %
Arvinas Inc   1.29 %
Pacira Biosciences inc   1.17 %
Waters Corporation  1.12 %
Cormedix Inc   1.11 %
Warby Parker Inc   1.05 %
Surgery Partners Inc   1.02 %
Staar Surgical Co  0.84 %
Biomarin Pharmaceutical Inc  0.82 %
Icu Medical Inc  0.75 %
Lifemd Inc   0.65 %

Date modified: 2026-09-12T06:23:51+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.